3
65
Growth Score
-15 pts
Heat Score
-26 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
530811
Score Pharma develops ADCC-enhanced monoclonal antibody therapeutics using CoreX technology.
- Bruce Edward Jones: Founder, President, and CEOPast Role: Anakim, Founder, President and Chief Science Officer
About the Company
Score Pharma leverages proprietary CoreX technology to develop ADCC-enhanced monoclonal antibody therapeutics. The company focuses on creating next-generation antibody-dependent cellular cytotoxicity (ADCC) enhancements to improve patient outcomes. Score Pharma operates within the pharmaceutical industry and specializes in drug discovery and
biotechnology research.
